U.S. Tech Hardware Stock News

Alcoa (AA) has grabbed investor attention after a sharp rally to three year highs, powered by stronger aluminum prices, tight supply conditions, and heavier trading interest in both shares and options. See our latest analysis for Alcoa. That surge in interest is showing up clearly in the numbers, with a 30 day share price return of 41.12% and a 90 day share price return of 69.57%. The 1 year total shareholder return of 76.51% points to strong upward momentum rather than a short lived...

In recent days, AngloGold Ashanti plc has re-emerged in investor discussions as a leveraged gold mining exposure used as a hedge against inflation and market volatility, drawing attention across financial social media. What stands out is that many investors now view AngloGold Ashanti as a more aggressive alternative to larger gold majors, aiming to amplify gold price moves rather than simply track them. We’ll now examine how AngloGold Ashanti’s appeal as a leveraged gold hedge may...

Nutex Health Inc. recently announced that its CEO, CFO, and President presented the company’s physician-led integrated healthcare model at the 2026 J.P. Morgan Healthcare Conference in San Francisco on January 14, 2026. This high-profile appearance offers Nutex Health a platform to explain how its micro-hospital and population health divisions fit into broader healthcare trends. We’ll now examine how Nutex Health’s high-profile J.P. Morgan Healthcare Conference presentation may influence its...

Worthington Enterprises (WOR) has been on many investors’ radar after recent share price moves, with the stock closing at $51.17 as of the latest session and short term returns turning negative. See our latest analysis for Worthington Enterprises. That weaker 1 day share price return of 2.63% and 30 day share price return of 7.27% come after a year to date share price return of 1.52%, while the 1 year total shareholder return of 31.05% and 3 year total shareholder return of 59.40% suggest...

In recent years, UMB Financial has delivered strong fundamental performance, including consistent net interest income growth, an expanded net interest margin, and earnings per share rising faster than revenue. This has been underpinned by a broadened mix of fee-based services such as asset servicing and treasury management, which helps balance pressures facing regional banks. Building on this, we’ll examine how UMB Financial’s resilient fee income and margin gains influence its existing...

Carvana (CVNA) is back in the spotlight after its S&P 500 inclusion and a sharp pickup in retail-unit growth, and investors are now treating the upcoming earnings report as a key check on its profitability push. See our latest analysis for Carvana. The latest move has taken Carvana’s share price to US$450.78, with a 90 day share price return of 25.21% and a 1 year total shareholder return of 128.82%, suggesting momentum has been building alongside S&P 500 inclusion, insider trading plan...

Agnico Eagle Mines (NYSE:AEM) is back in focus after analysts projected year-over-year earnings growth of 59.52% and revenue growth of 35.01% for its upcoming report, alongside a Zacks Rank of #1 (Strong Buy). See our latest analysis for Agnico Eagle Mines. The recent move to a share price of $182.07, alongside a 10.53% 1 month share price return and 12.58% 3 month share price return, sits against a very large 1 year total shareholder return of 121.20%, indicating that momentum has been...

SLB (NYSE:SLB) is back in focus after the U.S. military intervention in Venezuela sparked expectations that American oil companies could help rebuild the country’s damaged energy sector, which is shifting attention to oilfield service specialists. See our latest analysis for SLB. That Venezuela driven spike came on top of an already strong run, with a 90 day share price return of 27.89% and a 1 year total shareholder return of 12.63%, while the 3 year total shareholder return of an 18.90%...

If you are wondering whether MaxLinear's current share price reflects its underlying value, this article will walk through the key numbers so you can judge that for yourself. The stock last closed at US$18.65, with returns of 7.0% over the past week, a 4.4% decline over the past month, 0.8% year to date, and longer term returns of a 9.2% decline over 1 year, a 48.8% decline over 3 years, and a 49.5% decline over 5 years. These mixed returns have kept MaxLinear on the radar of investors who...

Why Gold Royalty Is Suddenly On Investors’ Radar Recent coverage of Gold Royalty (NYSEAM:GROY) has focused on its asset-light model, in which it collects royalties and streams from gold miners instead of operating mines itself. This structure is drawing renewed attention from volatility-tolerant investors. See our latest analysis for Gold Royalty. That speculative interest has coincided with strong recent share price momentum, with a 30-day share price return of 14.77% and a 90-day share...

Fastenal recently reported quarterly revenues of US$2.13 billion, up 11.7% year on year and broadly in line with analyst expectations, but EBITDA came in below estimates while earnings per share only matched forecasts. Despite the solid top-line growth, the combination of a slower quarter and profitability shortfall raises questions about how effectively Fastenal is converting expanding sales into sustainable earnings. We’ll now examine how this EBITDA miss, alongside slower quarterly...

CRA International stock triggered by recent performance CRA International (CRAI) has caught investor attention after a recent run that includes a 14.49% move over the past month and a 19.63% gain over the past 3 months, prompting a closer look at its fundamentals. See our latest analysis for CRA International. Looking beyond the recent run, CRA International’s 1-year total shareholder return of 17.86% and 5-year total shareholder return of 283.90% point to momentum that has built over time...

Edwards Lifesciences (EW) is back in focus after a series of upbeat analyst updates and fresh FDA approval for its SAPIEN M3 mitral valve replacement system. This development is one that investors are watching closely. See our latest analysis for Edwards Lifesciences. At a share price of $84.83, Edwards Lifesciences has seen short term share price returns move only slightly. Its 12.82% 90 day share price return and 14.40% 1 year total shareholder return indicate that momentum has been...

Why Scotts Miracle-Gro is on investors’ radar today Scotts Miracle-Gro (SMG) has attracted fresh attention after recent share price moves, with the stock closing at $58.92 and showing mixed performance over the past month and past 3 months. See our latest analysis for Scotts Miracle-Gro. Recent trading has been choppy, with a 1 day share price return of a 3.54% decline following a 30 day share price return of 12.49%. The 1 year total shareholder return of an 8.42% decline contrasts with a 3...

Wolfe Research recently upgraded Vertex Pharmaceuticals from “Peer Perform” to “Outperform,” citing a shifting outlook for its potential IgA nephropathy treatment, including the planned use of a priority review voucher to accelerate regulatory timelines. The upgrade highlights how competitive pricing moves in kidney disease and rising confidence in early‑2026 data for povetacicept could influence Vertex’s pipeline mix beyond cystic fibrosis. We’ll now explore how growing optimism around...

GE Vernova recently marked a technology milestone as its 9HA gas turbines entered commercial operation at Vietnam’s first LNG-powered 1.6 GW Nhon Trach 3&4 power plant, supporting grid reliability and cleaner power generation. This deployment, combined with a decline in short interest and growing international adoption of GE Vernova’s hardware and software, highlights building confidence in its role in the global energy transition. We’ll now examine how the Vietnam LNG power plant launch...

Why Trinity Industries is back on investors’ radar Trinity Industries (TRN) is drawing fresh attention after it overhauled railcar investment partnerships with Napier Park, raised 2025 earnings guidance, and flagged a sizeable non-cash gain tied to its Triumph Holdings exit. See our latest analysis for Trinity Industries. The guidance upgrade and restructuring news came after a mixed period, with a 7.01% year to date share price return but a 13.67% decline in 1 year total shareholder return...

Establishment Labs recently submitted its Motiva breast implants to the FDA for an expanded label covering primary and revision breast reconstruction, a major step for its reconstructive portfolio. An important follow-on milestone came when management appeared at the 44th Annual J.P. Morgan Healthcare Conference, giving investors fresh insight into how this potential label expansion could influence product positioning and future indications. We’ll now examine how the FDA submission for...

Recent commentary around Q2 Holdings (QTWO) has focused on slower annual recurring revenue growth, an expected deceleration in sales, and a gross margin level that trails peers, raising fresh questions for investors about the stock’s risk and reward. See our latest analysis for Q2 Holdings. Against that backdrop, Q2 Holdings’ share price of $71.50 sits after a 12.9% 90 day share price return and a 1 year total shareholder return decline of 28.4%. This suggests recent momentum is building from...

MasTec stock at a glance MasTec (MTZ) has been drawing fresh attention after recent share price moves, with the stock last closing at US$235.75. That has investors revisiting its infrastructure-focused business and current valuation. See our latest analysis for MasTec. Recent trading has been choppy, with a 1-day share price return of a 0.25% decline, a 7-day share price return of 8.46%, and a 90-day gain of 12.21%. Over the longer stretch, total shareholder returns of 60.84% over 1 year and...

Raymond James’ upgrade of Stryker (SYK) to “Outperform” has put the stock back in focus after the firm highlighted five years of double digit organic revenue growth and a stronger financial outlook. See our latest analysis for Stryker. The Raymond James upgrade appears to have acted as a fresh catalyst after a softer 90 day share price return of a 0.66% decline. The recent 7 day share price return of 4.63% and a 1 year total shareholder return of 1.94% suggest momentum is picking up from a...

Recently, OPENLANE, Inc. (NYSE: OPLN) announced an in-person Investor Day held on March 3, 2026, in Fort Lauderdale and expanded its Canadian receivables program limit to C$500 million with support from a lender group led by Royal Bank of Canada, alongside a ticker change from "KAR" to "OPLN" in December 2025. Together, these updates highlight OPENLANE’s emphasis on funding capacity, technology and operating plans, and clearer branding, giving investors more detail on how management is...

If you are looking at Alexandria Real Estate Equities and wondering whether the current share price still reflects its underlying worth, you are not alone. The stock trades at US$52.18, with returns of 6.6% over the last week and 16.0% over the last month, set against a 6.6% return year to date and a 43.0% decline over the past year, as well as 60.5% and 62.0% declines over the last 3 and 5 years. Recent moves in the share price have come against a backdrop of ongoing attention on listed...

Deere recently saw its shares lag the broader market after past trading sessions, as investors reacted to expectations of a sharp year-over-year earnings-per-share decline despite revenue growth ahead of its upcoming report. This tension between anticipated revenue expansion and weaker profitability has sharpened focus on how efficiently Deere is converting rising sales into bottom-line results. Against this backdrop of expected earnings pressure despite higher revenue, we’ll now examine...